Literature DB >> 15009006

Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.

Pamela Correa Buchwald1, Göran Akerström, Gunnar Westin.   

Abstract

OBJECTIVE: Hyperparathyroidism (HPT) refers to states of excessive production of parathyroid hormone (PTH). The eukaryotic cell cycle is driven forward by cyclins and their cyclin-dependent kinase (CDK) partners. Cyclin-dependent kinase inhibitors (CKIs), which generally inhibit cell cycle progression, modulate the activity of cyclin-CDK complexes.
DESIGN: In order to quantify the expression of the CKI genes p18, p21, and p27 semiquantitative RT-PCR with mRNA specific-primers was performed on four normal parathyroid biopsies, 31 parathyroid adenomas of primary HPT and 13 hyperplastic glands from uraemic patients with secondary HPT. PATIENTS: Parathyroid adenomas and secondary hyperplastic glands were obtained from 31 and 13 randomly selected patients undergoing parathyroidectomy in the clinical routine, respectively. Four normal parathyroid gland biopsies were obtained at surgery for pHPT or from normocalcemic patients undergoing thyroidectomy for goitre.
RESULTS: The relative p27 expression (p27/GAPDH) was significantly reduced in parathyroid adenomas compared to normal parathyroid gland biopsies. Furthermore, 42% and 53% of the parathyroid adenomas displayed undetectable p18 and p21 expression levels, respectively. All 13 adenomas that lacked p18 expression showed undetectable p21 expression. The p18 expression was significantly lower in tumours of uraemic sHPT as compared to normal parathyroids and an undetectable expression level was observed for p21 and p27 in 61% and 53%, respectively.
CONCLUSION: Parathyroid adenomas and secondary hyperplastic glands exhibit aberrant reduced expression of the CKIs p18, p21, and p27. This suggests that deranged collaboration of different CKIs may contribute to the development of both primary and secondary HPT.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15009006     DOI: 10.1111/j.1365-2265.2004.01995.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  11 in total

1.  Somatic mutation and germline sequence abnormalities in CDKN1B, encoding p27Kip1, in sporadic parathyroid adenomas.

Authors:  Jessica Costa-Guda; Ilaria Marinoni; Sara Molatore; Natalia S Pellegata; Andrew Arnold
Journal:  J Clin Endocrinol Metab       Date:  2011-02-02       Impact factor: 5.958

2.  Menin represses tumorigenesis via repressing cell proliferation.

Authors:  Ting Wu; Xianxin Hua
Journal:  Am J Cancer Res       Date:  2011-05-16       Impact factor: 6.166

3.  p18Ink4c, but not p27Kip1, collaborates with Men1 to suppress neuroendocrine organ tumors.

Authors:  Feng Bai; Xin-Hai Pei; Toru Nishikawa; Matthew D Smith; Yue Xiong
Journal:  Mol Cell Biol       Date:  2006-12-04       Impact factor: 4.272

4.  The tumor suppressors Ink4c and p53 collaborate independently with Patched to suppress medulloblastoma formation.

Authors:  Tamar Uziel; Frederique Zindy; Suqing Xie; Youngsoo Lee; Antoine Forget; Susan Magdaleno; Jerold E Rehg; Christopher Calabrese; David Solecki; Charles G Eberhart; Sarah E Sherr; Sarah Plimmer; Steven C Clifford; Mary E Hatten; Peter J McKinnon; Richard J Gilbertson; Tom Curran; Charles J Sherr; Martine F Roussel
Journal:  Genes Dev       Date:  2005-10-31       Impact factor: 11.361

5.  Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors.

Authors:  Thomas A Milne; Christina M Hughes; Ricardo Lloyd; Zhaohai Yang; Orit Rozenblatt-Rosen; Yali Dou; Robert W Schnepp; Cynthia Krankel; Virginia A Livolsi; Denise Gibbs; Xianxin Hua; Robert G Roeder; Matthew Meyerson; Jay L Hess
Journal:  Proc Natl Acad Sci U S A       Date:  2005-01-07       Impact factor: 11.205

6.  Rare germline mutations in cyclin-dependent kinase inhibitor genes in multiple endocrine neoplasia type 1 and related states.

Authors:  Sunita K Agarwal; Carmen M Mateo; Stephen J Marx
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

Review 7.  Molecular genetics of parathyroid disease.

Authors:  Gunnar Westin; Peyman Björklund; Göran Akerström
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 8.  Genetic and epigenetic changes in sporadic endocrine tumors: parathyroid tumors.

Authors:  Jessica Costa-Guda; Andrew Arnold
Journal:  Mol Cell Endocrinol       Date:  2013-09-11       Impact factor: 4.102

9.  Integrated Whole-Exome and Transcriptome Sequencing of Sporadic Parathyroid Adenoma.

Authors:  Ya Hu; Xiang Zhang; Ou Wang; Ming Cui; Xiaobin Li; Mengyi Wang; Surong Hua; Quan Liao
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-14       Impact factor: 5.555

Review 10.  Diagnosis, management, histology and genetics of sporadic primary hyperparathyroidism: old knowledge with new tricks.

Authors:  Maria Mizamtsidi; Constantinos Nastos; George Mastorakos; Roberto Dina; Ioannis Vassiliou; Maria Gazouli; Fausto Palazzo
Journal:  Endocr Connect       Date:  2018-01-12       Impact factor: 3.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.